Advertisement
YOU ARE HERE: LAT HomeCollectionsBiopool International Inc
IN THE NEWS

Biopool International Inc

FEATURED ARTICLES
BUSINESS
May 19, 1992
Biopool International Inc., a Ventura provider of medical diagnostic test kits, said it earned $121,496 in the first quarter, its first operating profit since the company's founding in 1987. The profit in the quarter that ended March 31 compared with a year-earlier loss of $48,301, and came on a 68% jump in its sales, to $1.18 million from $704,200.
ARTICLES BY DATE
BUSINESS
August 11, 1998 | BARBARA MURPHY
Biopool International in Ventura reported that sales for the second quarter ended June 30 were $3.9 million, with net income of $145,000, resulting in earnings of 2 cents per share. In the same period last year, sales were $4.2 million, with net income of $350,000 or 4 cents per share. The decrease in sales was largely due to the unavailability of an outsourced product distributed by the company, which has been on back order from the supplier since mid-February.
Advertisement
BUSINESS
March 22, 1994
Biopool International Inc., a Ventura maker of test kits for diagnosing blood disorders, said its profit increased 6% in the fourth quarter but its profits suffered a significant decline for 1993. For the quarter ended Dec. 31, Biopool reported a profit of $198,993, compared with earnings of $188,292 for the same period a year earlier. Revenue in the latest quarter rose 16% to $1.11 million, from $956,898.
BUSINESS
August 4, 1998 | Barbara Murphy
The U.S. Patent Office has issued a patent for the use of poultry antibodies to determine the number of blood cells in humans to the inventors of the technology, doctors Tomas Lindahl and Anders Larsson, clinical hemostasis researchers in Sweden. Biopool International in Ventura entered into an agreement with the inventors in 1994 to be the exclusive worldwide licensee of the technology and has funded expenses associated with obtaining the patent.
BUSINESS
March 10, 1992
Biopool International Inc., a Ventura company that makes blood diagnostic test kits and other blood-related products, said it acquired Medical Diagnostic Technologies Inc. in a stock swap valued at about $1.75 million. Medical Diagnostic, based in Ventura, also makes blood diagnostic test kits. Biopool said the acquisition would broaden its product offerings, about one-third of which have received market approval from the U.S. Food and Drug Administration.
BUSINESS
July 25, 1995
Biopool International Inc., a Ventura producer of medical test kits, said it has developed a new test that would pinpoint people at risk for heart attacks and strokes. The test was presented at a research conference in Israel last month, and focuses on blood platelets. Using the new test, researchers mix the antibodies of chickens with human blood platelets for analysis. The results screen out those at high risk of cardiovascular ailments.
BUSINESS
June 8, 1993
Biopool International Inc., a Ventura maker of blood-disorder diagnostic kits, said it completed a private placement of 1.17 million shares of its unregistered common stock. The stock was purchased by International Capital Partners Inc. of Stamford, Conn. and VK Capital Co. of San Francisco for $1.875 a share, or a total of about $2.2 million.
BUSINESS
May 18, 1993
Biopool International Inc., which makes test kits for diagnosing blood disorders, reported a 36% drop in earnings in the first quarter. The Ventura company said its profit in the three months ended March 31 was $78,349, down from net income of $121,496 a year before. Its revenue fell 13%, to $1.03 million from $1.18 million. Biopool said the results reflected lower sales from its Swedish subsidiary because of the decline in the value of the Swedish currency compared to the dollar.
BUSINESS
November 3, 1992 | JACK SEARLES
Biopool International Inc., a Ventura firm that produces medical diagnostic kits, has received approval from the Food and Drug Administration to market two new kits. The first, called the Minutex D-Dimer, tests patients for deep-vein thrombosis or blood clots, said Michael D. Bick, Biopool's chief executive. He said the kit is less costly and takes less time than other tests now being used.
BUSINESS
April 14, 1992 | JACK SEARLES
Biopool International Inc. of Ventura received approval from Mexico's Ministry of Health for the sale in that country of Biopool's blood diagnostic test kits. Dr. Michael Bick, Biopool's chief executive officer, declined to estimate how much the approval will add to his company's sales, but said, "We certainly think Mexico will become a major market for us." Biopool manufactures about 30 diagnostic kits used by hospitals and labs worldwide to test for blood and heart disorders.
BUSINESS
June 16, 1998 | BARBARA MURPHY
The board of directors for Biopool International in Ventura has approved a repurchase plan for up to 400,000 shares of its common stock. The action, taken at the annual board of directors meeting, is in response to the continued weakness in the company's stock price. The timing and amount of actual purchases of the company's stock will be determined by management over the next 12 months, officials said.
BUSINESS
March 10, 1998 | BARBARA MURPHY
Biopool International in Ventura has selected ESBE Scientific of Markham, Ontario, as the new distributor for Biopool products in Canada. The company announced in December that it would close its Canadian subsidiary, Biopool Canada, by June of this year. The company needed to find new distribution lines "to continue to support our existing customer base in Canada and, more importantly, provide a new marketing focus for our full range of products," said Biopool chairman and CEO Michael D. Bick.
BUSINESS
December 30, 1997 | BARBARA MURPHY
Biopool International announced that the company will restructure its operations by closing its Canadian facilities and consolidating the operations of its subsidiary, Biopool Canada, with the company's Ventura facilities. "This is a matter that our board of directors has been reviewing for quite some time," said Michael D. Bick, Biopool chairman and chief executive officer.
BUSINESS
October 28, 1997 | BARBARA MURPHY
Biopool International in Ventura reported that sales more than doubled for the third quarter ended Sept. 30, and net income rose 50%. Sales jumped to $4.3 million from $2 million in the third quarter of 1996. Net income for the quarter increased to $493,000 or 6 cents per share, from $327,000 or 4 cents per share for the same period in 1996. Michael D.
BUSINESS
July 15, 1997 | BARBARA MURPHY
Biopool International in Ventura elected the nominated slate of directors at its annual shareholders meeting but lacked sufficient votes to authorize the issuance of preferred stock as a means of raising capital. Despite a decision to adjourn the meeting for 30 days to try to garner sufficient participation by shareholders to approve the preferred stock matter, not enough votes were cast to authorize it.
BUSINESS
December 31, 1996 | BARBARA MURPHY
Biopool International in Ventura has completed a private placement of 500,000 shares of common stock to help fund the acquisition of another company. The stock, at $2.1875 per share, brought an aggregate purchase price of $1.09 million, company officials said. The net proceeds from the offering will be used for Biopool's acquisition of the Blood Group Serology business unit of Organon Teknika Corp.
BUSINESS
May 10, 1994
Biopool International Inc., a Ventura maker of test kits for diagnosing blood disorders, reported a $200,196 first-quarter profit compared with net income of $78,349 a year ago. The company's sales for the quarter that ended March 31 was $1.28 million, up 24% from $1.03 million in sales in the first quarter of 1993. Biopool attributed the improved results to growth in its Swedish subsidiary, Biopool AB, which benefited from approval for insurance reimbursement of a test kit in Japan.
BUSINESS
January 9, 1996 | JACK SEARLES
Two Ventura County producers of medical test kits have settled a pair of costly lawsuits involving trade secrets. Under the settlement, Biopool International Inc., based in Ventura, will pay $100,000 to Medical Analysis Systems Inc., which has its headquarters in Camarillo. Biopool also agreed to pay royalties to Medical Analysis for the right to manufacture and sell certain drug-abuse control products.
Los Angeles Times Articles
|